2.165
Schlusskurs vom Vortag:
$2.23
Offen:
$2.24
24-Stunden-Volumen:
174.36K
Relative Volume:
0.16
Marktkapitalisierung:
$238.93M
Einnahmen:
$21.05M
Nettoeinkommen (Verlust:
$-142.93M
KGV:
-1.5581
EPS:
-1.3895
Netto-Cashflow:
$-184.07M
1W Leistung:
+8.00%
1M Leistung:
+15.51%
6M Leistung:
-21.45%
1J Leistung:
+51.05%
Alector Inc Stock (ALEC) Company Profile
Firmenname
Alector Inc
Sektor
Branche
Telefon
415-231-5660
Adresse
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ALEC
Alector Inc
|
2.165 | 246.11M | 21.05M | -142.93M | -184.07M | -1.3895 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.28 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
743.73 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
695.77 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.53 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.50 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-10-22 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-10-22 | Herabstufung | Mizuho | Outperform → Neutral |
| 2025-10-22 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-22 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-07-28 | Hochstufung | Mizuho | Neutral → Outperform |
| 2024-12-17 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-12-16 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-11-29 | Bestätigt | H.C. Wainwright | Buy |
| 2024-11-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-12-14 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-09-25 | Eingeleitet | Goldman | Sell |
| 2023-09-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-09-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-13 | Eingeleitet | Goldman | Sell |
| 2022-03-08 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-27 | Eingeleitet | William Blair | Outperform |
| 2021-01-15 | Fortgesetzt | BofA Securities | Buy |
| 2020-06-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-28 | Eingeleitet | Goldman | Buy |
| 2020-03-06 | Eingeleitet | Citigroup | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-02-19 | Eingeleitet | Stifel | Buy |
| 2019-11-21 | Eingeleitet | BTIG Research | Buy |
| 2019-03-04 | Eingeleitet | Barclays | Overweight |
| 2019-03-04 | Eingeleitet | BofA/Merrill | Buy |
| 2019-03-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-03-04 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Alector Inc Aktie (ALEC) Neueste Nachrichten
Stock Recap: What is the dividend yield of Alector IncMarket Volume Report & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Insider Sell Alert: Grace Wong-sarad Sells Shares of Alector Inc (ALEC) - GuruFocus
Alector Stock Jumps On Upgrade, But AL101 Interim Data Will Be Key (NASDAQ:ALEC) - Seeking Alpha
Alector (ALEC) Shares Surge After Strategic Shift and Analyst Up - GuruFocus
Alector stock upgraded at BTIG (ALEC:NASDAQ) - Seeking Alpha
Alector (ALEC)'s Technical Outlook is Bright After Key Golden Cross - Finviz
Wall Street Turns Bullish on HIMS, TDOC and ALEC as Partnerships Reshape Risk Profiles - AOL.com
Alector stock rating upgraded to Buy at BTIG on BBB-shuttle focus - Investing.com Australia
Alector (NASDAQ:ALEC) Stock Rating Upgraded by BTIG Research - MarketBeat
This CrowdStrike Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Analyst BTIG Upgrades Alector (ALEC) to 'Buy' with a New Price T - GuruFocus
Alector (ALEC) Receives Upgrade: A Shift in Focus to Neurodegenerative Therapies - GuruFocus
Aug EndMonth: Is Alector Inc. undervalued by DCF analysis2026 Pullbacks & Safe Entry Zone Tips - baoquankhu1.vn
Street Watch: Is Alector Inc a cyclical or defensive stock2025 Earnings Impact & Community Trade Idea Sharing Platform - baoquankhu1.vn
How The Alector (ALEC) Story Is Shifting As Analyst Targets And Sector Views Evolve - Yahoo Finance
Alector Showcases ABC Brain-Delivery Platform, AL137 and AL050 Updates at TD Cowen Conference - Yahoo Finance
Insider Sell: Grace Wong-sarad Sells Shares of Alector Inc (ALEC) - GuruFocus
Alector at TD Cowen Conference: Advancing Brain Therapeutics By Investing.com - Investing.com Canada
Alector at TD Cowen Conference: Advancing Brain Therapeutics - Investing.com Nigeria
Alector (ALEC) accounting chief sells 3,367 shares under 10b5-1 plan - Stock Titan
Alector (ALEC) accounting officer sells shares to cover RSU tax bill - Stock Titan
RSU tax sale: Alector (NASDAQ: ALEC) CEO sells 81,864 shares - Stock Titan
Alector (ALEC) CFO sells 29,649 shares to cover RSU tax obligations - Stock Titan
HC Wainwright Estimates Alector FY2030 Earnings - MarketBeat
ALEC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Alector (NASDAQ:ALEC) Stock Rating Lowered by Wall Street Zen - MarketBeat
Analysts Have Conflicting Sentiments on These Healthcare Companies: Xenon (XENE), Alector (ALEC) and Caris Life Sciences, Inc. (CAI) - The Globe and Mail
Neil Berkley sale 37,261 shares; ALEC (NASDAQ: ALEC) RSUs vest 45,520 - Stock Titan
Alector (ALEC) Posts Steep US$37 Million Quarterly Loss Testing Bullish Pipeline Narratives - simplywall.st
Alector (NASDAQ:ALEC) Insider Grace Wong-Sarad Sells 4,079 Shares - MarketBeat
Alector (ALEC) accounting chief sells 4,079 shares via 10b5-1 plan - Stock Titan
[144] Alector, Inc. SEC Filing - Stock Titan
ALEC SEC FilingsAlector 10-K, 10-Q, 8-K Forms - Stock Titan
Alector earnings beat by $0.05, revenue topped estimates - Investing.com Canada
Alector (ALEC) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Alector (NASDAQ:ALEC) Announces Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
Alector Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Alector : February 2026 Corporate Presentation - marketscreener.com
Alector: Q4 Earnings Snapshot - marketscreener.com
Alector, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Alector (Nasdaq: ALEC) 2025 revenue drops as R&D falls and cash tops $256M - Stock Titan
Alector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - marketscreener.com
Investors Purchase High Volume of Alector Call Options (NASDAQ:ALEC) - MarketBeat
Alector (ALEC) Stock Analysis Report | Ratings, Financials & Performance - Benzinga España
Alector to Participate in the TD Cowen 46th Annual Health Care Conference - Bitget
Alector (NASDAQ:ALEC) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Alector Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView
Alector, Inc. (NASDAQ:ALEC) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Alector (ALEC) to Release Earnings on Wednesday - MarketBeat
What The New Sector Driven Price Target Means For Alector's Story And Valuation - Yahoo Finance
Why Alector Inc. stock could outperform in 2025CEO Change & AI Driven Stock Price Forecasts - mfd.ru
Finanzdaten der Alector Inc-Aktie (ALEC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):